pharmaceutical daily

January 27, 2017 Off

UPDATE: Lilly breaks up partnership deal with Adocia on diabetes BC Lispro study

UPDATE contains comment from Lilly
Eli Lilly has quit from a research and licence agreement with a Paris-listed clinical stage pharmaceutical company Adocia, the French company said on Friday.

January 27, 2017 Off

Roche cancer drug taking bite out of Bristol’s Opdivo

By Dino Mustafić

Roche’s cancer drug Tecentriq hit the market months behind immuno-oncology (I/O) medicines from Merck and Bristol-Myers Squibb Co but the Swiss drugmaker’s treatment is making up lost ground.

January 27, 2017 Off

Itchy skin? Dermatologists share tips for relief

By Dino Mustafić

Everyone gets an itch once in a while. Usually it only lasts for a short time and is often caused by annoyances like a mosquito bite or scratchy fabric. However, if an itch lasts for more than six weeks, say dermatologists from the American Academy of Dermatology, it is considered a chronic itch and is more likely to disrupt your life.

January 27, 2017 Off

AbbVie’s fourth quarter earnings down, but generates $809M more than 2015 full year

By Dino Mustafić

The fourth quarter was a continuation of the strong performance and business momentum AbbVie has delivered since becoming an independent company in 2013.

January 27, 2017 Off

Theradiag and its South Korean partners get financial support for rectal cancer study

By Dino Mustafić

Theradiag and its South Korean partners, Professor Chang-sik Yu and his team at Asan Medical Center and CbsBioscience will receive €1.3 million financial support from Eurostars program for its Pioneer collaborative project undertaken by its Prestizia molecular biology platform.

January 27, 2017 Off

French Poxel exectedly falls short on revenue in Q4 2016

By Dino Mustafić

French drugmaker focused on diabetes treatments Poxel, said it expectedly did not generate meaningful revenues in the fourth quarter of 2016, but it is on track for developing two of its programs.

January 27, 2017 Off

The Vetoquinol Goup sales 4.3% up in 2016

By Dino Mustafić

The Vetoquinol Group has reported sales of €350.3 million for 2016, representing like-for-like growth of 4.3%.

January 27, 2017 Off

Beximco 16% sales rise drives profit up for the half year

By Dino Mustafić

Beximco Pharmaceuticals has posted earnings of $1,113,722, for the second half of 2016, compared to $944,662 to the same period last year.

January 27, 2017 Off

Stallergenes reports positive results for a p3 clinical study of allergic rhinitis in children

By Dino Mustafić

Stallergenes Greer, a biopharmaceutical company specializing in treatments for respiratory allergies, has reported positive topline results for a phase 3 clinical…

January 27, 2017 Off

FDA asks Hyland’s teething tablets maker to recall medicines containing belladonna

By Dino Mustafić

FDA found that certain teething tablets for children sometimes exceed the amount of belladonna – a toxic substance – and has asked the company that makes them to recall such medicine.